Organic Letters
Letter
Notes
Scheme 5. Proposed Mechanism
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
Financial support was provided by the National Program on
Key Research Project (2016YFA0602900), the National
Natural Science Foundation of China (21702064,
21420102003), the Pearl River S&T Nova Program of
Guangzhou (201806010138), and the Fundamental Research
Funds for the Central Universities (2019ZD19).
further converted to trifluoromethylated diazo intermediate C
via the elimination of HBr in the presence of base. The
subsequent facile and chemoselective 1,3-hydrogen atom
transfer (1,3-HAT) of trifluoromethylated diazo intermediate
C provided diazo intermediate D, which featured a proton at
the α-position of the CF3 group.14 Finally, the 1,3-HAT of
intermediate D afforded the desired product 2a.4a
REFERENCES
■
(1) (a) Lamberth, C. Heterocycles 2007, 71, 1467. (b) Yet, L.
Comprehensive Hetereocylic Chemistry III; Elsevier: Oxford, U.K., 2008.
(c) Elguero, J.; Silva, A. M. S.; Tome, A. C. Modern Heterocyclic
́
Chemistry; Wiley-VCH: Weinheim, Germany, 2011; p 635.
In summary, we have reported a general and practical
strategy for 3-trifluoromethylpyrazole synthesis by coupling
environmentally friendly and large-tonnage industrial feedstock
BTP with aldehydes and sulfonyl hydrazides. This highly
regioselective three-component coupling reaction is metal-free,
catalyst-free, and operationally simple and features mild
conditions, a broad substrate scope, high yields, and valuable
functional group tolerance. Remarkably, the reactions could be
performed on a 100 mmol scale and smoothly afforded the key
intermediates for the synthesis of celecoxib, mavacoxib, SC-
560, and AS-136A. Preliminary mechanism studies indicated
that a 1,3-HAT process was involved in this transformation. An
investigation of the mechanistic details and an exploration of
other potential applications of BTP are currently underway in
our laboratory, the results of which will be reported in due
course.
́
́
́
(d) Fustero, S.; Sanchez-Rosello, M.; Barrio, P.; Simon-Fuentes, A.
Chem. Rev. 2011, 111, 6984. (e) Chen, Z.; Zheng, Y.; Ma, J.-A. Angew.
Chem., Int. Ed. 2017, 56, 4569.
(2) (a) Penning, T. D.; Talley, J. J.; Bertenshaw, S. R.; Carter, J. S.;
Collins, P. W.; Docter, S.; Graneto, M. J.; Lee, L. F.; Malecha, J. W.;
Miyashiro, J. M.; et al. J. Med. Chem. 1997, 40, 1347. (b) Cox, S. R.;
Lesman, S. P.; Boucher, J. F.; Krautmann, M. J.; Hummel, B. D.;
Savides, M.; Marsh, S.; Fielder, A.; Stegemann, M. R. J. Vet.
Pharmacol. Ther. 2010, 33, 461. (c) Lee, E.; Choi, M. K.; Youk, H. J.;
Kim, C. H.; Han, I. C.; Yoo, B. C.; Lee, M. K.; Lim, S. J. J. Cancer Res.
Clin. Oncol. 2006, 132, 223. (d) Pruitt, J. R.; Pinto, D. J. P.; Galemmo,
R. A.; Alexander, R. S.; Rossi, K. A.; Wells, B. L.; Drummond, S.;
Bostrom, L. L.; Burdick, D.; Bruckner, R.; Chen, H.; Smallwood, A.;
Wong, P. C.; Wright, M. R.; Bai, S.; Luettgen, J. M.; Knabb, R. M.;
Lam, P. Y. S.; Wexler, R. R. J. Med. Chem. 2003, 46, 5298. (e) Sun, A.;
Chandrakumar, N.; Yoon, J.-J.; Plemper, R. K.; Snyder, J. P. Bioorg.
Med. Chem. Lett. 2007, 17, 5199. (f) Varnes, J. G.; Wacker, D. A.;
Pinto, D. J. P.; Orwat, M. J.; Theroff, J. P.; Wells, B.; Galemo, R. A.;
Luettgen, J. M.; Knabb, R. M.; Bai, S.; He, K.; Lam, P. Y. S.; Wexler,
R. R. Bioorg. Med. Chem. Lett. 2008, 18, 749. (g) Lahm, G. P.; Selby,
T. P.; Freudenberger, J. H.; Stevenson, T. M.; Myers, B. J.;
Seburyamo, G.; Smith, B. K.; Flexner, L.; Clark, C. E.; Cordova, D.
Bioorg. Med. Chem. Lett. 2005, 15, 4898.
ASSOCIATED CONTENT
* Supporting Information
■
sı
The Supporting Information is available free of charge at
(3) Selected examples: (a) Norris, T.; Colon-Cruz, R.; Ripin, D. H.
B. Org. Biomol. Chem. 2005, 3, 1844. (b) Shavnya, A.; Sakya, S. M.;
Minich, M. L.; Rast, B.; Lundy DeMello, K.; Jaynes, B. H. Tetrahedron
Lett. 2005, 46, 6887. (c) Singh, S. P.; Kumar, V.; Aggarwal, R.;
Elguero, J. J. Heterocycl. Chem. 2006, 43, 1003. (d) Humphries, P. S.;
Finefield, J. M. Tetrahedron Lett. 2006, 47, 2443. (e) Yonetoku, Y.;
Kubota, H.; Okamoto, Y.; Toyoshima, A.; Funatsu, M.; Ishikawa, J.;
Takeuchi, M.; Ohta, M.; Tsukamoto, S.-I. Bioorg. Med. Chem. 2006,
Typical experimental procedures and characterization
AUTHOR INFORMATION
Corresponding Authors
■
Chuanle Zhu − South China University of Technology,
Huanfeng Jiang − South China University of Technology,
́
14, 4750. (f) Montoya, V.; Pons, J.; García-Anton, J.; Solans, X.; Font-
Bardia, M.; Ros, J. J. Fluorine Chem. 2007, 128, 1007. (g) Fustero, S.;
́
́
Roman, R.; Sanz-Cervera, J. F.; Simon-Fuentes, A.; Cunat, A. C.;
̃
Villanova, S.; Murguía, M. J. Org. Chem. 2008, 73, 3523. (h) Dai, H.;
Li, Y.-Q.; Du, D.; Qin, X.; Zhang, X.; Yu, H.-B.; Fang, J.-X. J. Agric.
Food Chem. 2008, 56, 10805. (i) Yang, X.; Shui, S.; Chen, X.; He, H.;
Wu, F. J. Fluorine Chem. 2010, 131, 426. (j) Muzalevskiy, V. M.;
Rulev, A. Y.; Romanov, A. R.; Kondrashov, E. V.; Ushakov, I. A.;
Chertkov, V. A.; Nenajdenko, V. G. J. Org. Chem. 2017, 82, 7200.
(4) (a) Li, F.; Nie, J.; Sun, L.; Zheng, Y.; Ma, J.-A. Angew. Chem., Int.
Ed. 2013, 52, 6255. (b) Zhang, F.-G.; Wei, Y.; Yi, Y.-P.; Nie, J.; Ma, J.-
A. Org. Lett. 2014, 16, 3122.
Other Authors
Hao Zeng − South China University of Technology,
Guangzhou, P. R. China
Chi Liu − South China University of Technology,
Guangzhou, P. R. China
Yingying Cai − South China University of Technology,
Guangzhou, P. R. China
Xiaojie Fang − South China University of Technology,
Guangzhou, P. R. China
(5) Britton, J.; Jamison, T. F. Angew. Chem., Int. Ed. 2017, 56, 8823.
́
(6) (a) Multicomponent Reaction; Zhu, J., Bienayme, H., Eds.; Wiley-
VCH: Weinheim, Germany, 2005. (b) Ruijter, E.; Scheffelaar, R.;
Orru, R. V. A. Angew. Chem., Int. Ed. 2011, 50, 6234. (c) de Graaff, C.;
Ruijter, E.; Orru, R. V. A. Chem. Soc. Rev. 2012, 41, 3969. (d) Cioc, R.
C.; Ruijter, E.; Orru, R. V. A. Green Chem. 2014, 16, 2958. (e) Hulme,
C.; Ayza, M.; Martinez-Ariza, G.; Medda, F.; Shaw, A. Y. Recent
Advances in Multi-Component Reaction Chemistry: Applications in
Complete contact information is available at:
D
Org. Lett. XXXX, XXX, XXX−XXX